Twist Bioscience Corporation (TWST)

USD 34.56

(-6.09%)

Long Term Debt Summary of Twist Bioscience Corporation

  • Twist Bioscience Corporation's latest annual long term debt in 2023 was 79.17 Million USD , down -2.58% from previous year.
  • Twist Bioscience Corporation's latest quarterly long term debt in 2024 Q3 was 72.62 Million USD , down 0.0% from previous quarter.
  • Twist Bioscience Corporation reported annual long term debt of 81.27 Million USD in 2022, up 52.89% from previous year.
  • Twist Bioscience Corporation reported annual long term debt of 53.15 Million USD in 2021, up 102.58% from previous year.
  • Twist Bioscience Corporation reported quarterly long term debt of 74.8 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Twist Bioscience Corporation reported quarterly long term debt of 77.07 Million USD for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Twist Bioscience Corporation (2023 - 2016)

Created with Highcharts 11.1.0YearsLong Term Debt201620172018201920202021202220230 USD100000000 USD25000000 USD50000000 USD75000000 USD

Historical Annual Long Term Debt of Twist Bioscience Corporation (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 79.17 Million USD -2.58%
2022 81.27 Million USD 52.89%
2021 53.15 Million USD 102.58%
2020 26.24 Million USD 496.36%
2019 4.4 Million USD -39.04%
2018 7.21 Million USD -21.15%
2017 9.15 Million USD -6.73%
2016 9.81 Million USD 0.0%

Peer Long Term Debt Comparison of Twist Bioscience Corporation

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -2475.569%
Applied DNA Sciences, Inc. 739.16 Thousand USD -10611.184%
Aspira Women's Health Inc. 1.43 Million USD -5436.573%
Biodesix, Inc. 35.22 Million USD -124.764%
BioNexus Gene Lab Corp. 98.76 Thousand USD -80064.637%
bioAffinity Technologies, Inc. 1.11 Million USD -6978.701%
bioAffinity Technologies, Inc. 1.11 Million USD -6978.701%
Bionano Genomics, Inc. 7.17 Million USD -1003.456%
CareDx, Inc 28.27 Million USD -179.981%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD -457.635%
DarioHealth Corp. 24.59 Million USD -221.959%
Exact Sciences Corporation 2.47 Billion USD 96.802%
Fulgent Genetics, Inc. 10.11 Million USD -683.038%
Guardant Health, Inc. 1.13 Billion USD 93.055%
ICON Public Limited Company 3.66 Billion USD 97.84%
IDEXX Laboratories, Inc. 622.88 Million USD 87.289%
Illumina, Inc. 1.48 Billion USD 94.683%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -97255.024%
iSpecimen Inc. 29.13 Thousand USD -271691.967%
Standard BioTools Inc. 3.98 Million USD -1887.773%
MDxHealth SA 35.56 Million USD -122.621%
23andMe Holding Co. 67.84 Million USD -16.697%
Medpace Holdings, Inc. 142.12 Million USD 44.292%
Myriad Genetics, Inc. 130.9 Million USD 39.516%
Mainz Biomed B.V. 2.19 Million USD -3505.51%
ENDRA Life Sciences Inc. 192.06 Thousand USD -41122.626%
NeoGenomics, Inc. 606.06 Million USD 86.937%
Neogen Corporation 888.39 Million USD 91.088%
Inotiv, Inc. 399.4 Million USD 80.177%
Natera, Inc. 282.94 Million USD 72.018%
OpGen, Inc. 2.02 Million USD -3816.322%
OPKO Health, Inc. 222.03 Million USD 64.342%
Psychemedics Corporation 945 Thousand USD -8278.095%
Prenetics Global Limited 867.21 Thousand USD -9029.57%
Prenetics Global Limited 867.21 Thousand USD -9029.57%
Precipio, Inc. 106 Thousand USD -74591.509%
Personalis, Inc. 1.23 Million USD -6315.964%
RadNet, Inc. 812.06 Million USD 90.25%
Sera Prognostics, Inc. 840 Thousand USD -9325.357%
Sotera Health Company 2.22 Billion USD 96.44%
Neuronetics, Inc. 59.28 Million USD -33.551%
Star Equity Holdings, Inc. 1.14 Million USD -6814.672%
Star Equity Holdings, Inc. 1.14 Million USD -6814.672%
Trinity Biotech plc 54.65 Million USD -44.87%
T2 Biosystems, Inc. 6.59 Million USD -1099.955%
Exagen Inc. 19.23 Million USD -311.695%